Latest posts
-
Day 7 Euploid Embryos: A 24.1% Live Birth Rate, Not a Lost Cause

Can day 7 embryos lead to a baby? A study of 3,338 euploid frozen embryo transfers found lower live birth rates, but meaningful potential for D7 embryos.
-
Sleep and Fertility: Sperm Quality, Implantation and IVF Outcomes

Studies link sleep quality and breathing disorders with semen measures and IVF outcomes. Understand the evidence without confusing association with causation.
-
Pregnancy and Biological Aging: Can the Clock Reverse After Birth?

Pregnancy can increase some epigenetic age measures, while postpartum recovery may reverse them. Explore the evidence, parity findings and limitations.
-
Fluid in the Uterus Before FET: What It Means for Live Birth

Fluid during frozen embryo transfer preparation was linked to lower live birth rates. Size and cause matter, but 2.55 mm is not a cancellation rule.
-
FMR1 Premutation and IVF: Fewer Eggs, Similar Embryo Euploidy

FMR1 premutation carriers may retrieve fewer eggs without lower euploidy among tested blastocysts. Explore the IVF study, genetics and key limitations.
-
Blastocyst Collapse in IVF: What Does It Mean for Pregnancy?

A time-lapse study links blastocyst collapse and cytoplasmic strings with embryo quality and early pregnancy. Learn the findings and their limitations.
-
Non-Invasive PGT-A in IVF: What Culture-Medium DNA May Reveal

Early IVF research examines DNA fragment patterns in culture medium for clues to embryo chromosomes. Learn what it found and why biopsy remains standard.
-
Low AMH and Egg Quality: What an FMR1 IVF Study Found

FMR1 premutation carriers produced fewer eggs, but the chromosome-normal rate per biopsied blastocyst was comparable with matched controls. The findings do not apply to every cause of low AMH or every aspect of egg quality.
-
IVF With Diabetes, Hypertension or Obesity: Live Birth Evidence

Studies link type 2 diabetes, hypertension and obesity with lower live-birth outcomes after assisted reproduction. Findings differ for type 1 diabetes and hypothyroidism, making preconception health assessment important.
-
Embryo Fragmentation in IVF: What the DEBRIS Trial Will Test

The DEBRIS trial will test whether removing cytoplasmic fragments from day-4 embryos improves blastocyst development and pregnancy outcomes. It is recruiting, with no results posted.